期刊文献+

人脂联素基因在L-02细胞中表达及其功能检测 被引量:1

Expression and Characterization of Human Adiponectin in L-02 Cells
下载PDF
导出
摘要 目的:在人正常肝细胞株L-02中表达外源人脂联素蛋白,并观察其生物学活性。方法:采用脂质体法将成功构建的人脂联素真核表达质粒pcDNA3.1/CT-GFP-TOPO-Adiponectin转染L-02细胞;免疫组织化学定位观察脂联素的表达;Western blot检测培养上清及细胞沉淀中脂联素水平;酶联免疫法测定培养基血糖。结果:构建的真核表达质粒能有效转染L-02细胞,并在培养上清及细胞沉淀中检测到脂联素蛋白,该重组蛋白能够降低高糖处理的L-02细胞的血糖水平。结论:重组人脂联素蛋白能在L-02中有效表达,该蛋白定位在细胞质,并且能分泌到胞外,表达产物经体外实验证实具有生物学活性。 Objective: To express exogenous human adiponectin protein in Homo hepatocytes named L-02,and to observe its bioactivity. Methods: The eukaryotic expression vector pcDNA3.1/CT-GFP-TOPO-Adiponectin was transfected human hepatocytes named L-02 with liposome. The expression of adiponectin protein was observed using immuneohistochemistry. The level of human adiponectin protein in the supernatant of cell culture media and precipitation was detected with western blot, and the culture medium glucose was determined by enzyme linked immunosorbent assay. Results: The eukaryotic expression vector could transfected L-02 effectively. The human adiponectin protein could be detected in culture supernatant, and could significantly reduce the level of blood glucose in hyperglycemia mode of L-02 cells. Conclusion: The recombinant adiponectin protein was successfully expressed in L-02 cells,and the adiponectin protein distributed in cell plasma and succeed to secrete. This expression product has a bioactivity in vitro.
出处 《天津医药》 CAS 北大核心 2008年第4期246-248,共3页 Tianjin Medical Journal
基金 天津市教委基金项目(项目编号:2003025) 天津市自然科学基金资助项目(项目编号:043609211)
关键词 脂联素 基因表达 基因转移技术 遗传载体 重组蛋白 脂质体 adiponectin gene expression gene transfer techniques genetic vectors recombinant proteins liposome
  • 相关文献

参考文献6

  • 1Qi Y, Takahashi N, Heliman SM, et al. Adiponectin acts in the brain to decrease body weight[J]. Nat Med, 2004,10(5) : 524-529.
  • 2Lindmark S,Buren J,Eriksson JW. Insulin resistance,endocrine function and adipokines in type2 diabetes patients at different glycaemic levels: potential impact for glucotoxicity in vivo [J]. Clin Endocrinol (Oxf), 2006,65(3) :301-309.
  • 3Manigrasso MR, Ferroni P, Santilli F,et al. Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss [J]. Clin Endocrinol Metab,2005,90 (10): 5876-5879.
  • 4刘德敏,靳立忠,孙颖,张捷.人脂联素cDNA的克隆及序列分析[J].天津医药,2005,33(2):71-73. 被引量:5
  • 5刘德敏,杜春红,孙颖,张捷.绿色荧光蛋白标记的人脂联素真核表达载体的构建[J].天津医药,2007,35(5):324-325. 被引量:1
  • 6Kadowaki T,Yamauchi T,Kubota N,et al. Adiponectin and adipon ectin receptors in insulin resistance, diabetes, and the metabolic syndrome[J]. J Clin Invest, 2006,116( 7 ) : 1784-1792.

二级参考文献18

  • 1刘德敏,靳立忠,孙颖,张捷.人脂联素cDNA的克隆及序列分析[J].天津医药,2005,33(2):71-73. 被引量:5
  • 2Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol M etab, 2001, 86:1930-1935.
  • 3Yokota T, Oritani K, Takahashi I, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytie progenitors and the function of maerophages.Blood, 2000, 96:1723-1732.
  • 4Takahashi M, Arita Y, Yamagata K, et al. Genomic structure and mutations in adipose-specific gene, adiponeetin, Int J Obes, 2000, 24: 861-868.
  • 5Shapiro L, Scherer PE.The crystal structure of a complement-lq family protein suggests an evolutionary link to tumor necrosis factor.Curt Biol, 1998, 12:335-338.
  • 6Arita Y, Kihara S, Ouchi N, et al. Parodoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun, 1999, 257:79-83.
  • 7Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hypefinsulinemia. J Clin Endocfinol Metab, 2001, 86:1930-1935.
  • 8Fruebis J, Tsao TS, Javorschi S, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice.Proc Natl Acad sci USA, 2001, 98:2005-2010.
  • 9Berg AH, Combs TP, Du X, et al. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med, 2001, 7:947-953.
  • 10Combs TP, Berg AH, Obicis, et al. Endogenous glucose prodution is inhibited by the adipose-derived protein Acrp 30. J Clin Invest,2001, 108(12): 1875-1881.

共引文献4

同被引文献2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部